Test Directory
Plavix Sensitivity Genotype (CYP2C19)
Justification
Plavix (clopidogrel) is a commonly prescribed antiplatelet medication for the prevention of arterial thrombosis. A significant subset of patients treated with clopidogrel do not show adequate antiplatelet response due to factors such as variability in drug metabolism, drug interactions, and compliance, leading to increased risk of recurrent cardiovascular events.
Plavix is a prodrug that is converted to its active metabolite in the liver by the cytochrome P450 enzyme system. Plavix sensitivity genotyping of CYP2C19 can be used to detect the presence of alleles (CYP2C19*2, CYP2C19*3) that lead to decreased metabolism and reduced conversion of Plavix to its active form (Plavix "resistance"), or alleles (CYP2C19*17) that lead to increased metabolism and conversion of Plavix to its active form.
STAT: < 48 hours (M-F)
RT-PCR
Draw Tube: Purple Top
Sample Type: EDTA Whole Blood
Specimen Requirements
Sample Type | Volume Required | Minimum Volume | Stability | |
---|---|---|---|---|
PREFERRED | EDTA Whole Blood | 3mL | 1mL | Room Temp.: 1 month Refrigerated: 1 month |
ALTERNATIVE | Cheek swab | 2 swab | - | Room Temp.: 1 month Refrigerated: 1 month |
REJECTION CRITERIA | Sample contamination; sample compromised |
SPECIAL INSTRUCTIONS | - |
General Information
METHODOLOGY | RT-PCR |
STAT TAT | < 48 hours (M-F) |
STAT TAT Performance | > 90% of results released in 48 hours |
ROUTINE TAT | < 1 week |
ALTERNATIVE NAMES | Plavix genetic test, P2Y12 genetic test |
DESCRIPTION | This test detects the -806C>T (CYP2C19*17), 17948G>A (CYP2C19*3), and 19154G>A (CYP2C19*2) variants using real-time PCR. It can detect individuals who are homozygous or heterozygous for each of the three variants, or individuals who carry none of the variants (CYP2C19*1/*1 individuals). |
LIMITATIONS | This test does not detect CYP2C19 genotypes other than *2, *3, or *17. Other genotypes which may influence Plavix metabolism are not detected by this test, and individuals carrying these other genotypes will be identified as CYP2C19*1/*1 (normal metabolism) individuals. |
NORMAL RANGE | Interpretation |
ASSOCIATED TESTING | - |
REFERENCES | - |
SAMPLE REPORT | Upon request |
NEW YORK STATE APPROVED | No |
Test Codes
ORDER CODE | P3051 |
CPT CODE | 81225 |
LOINC CODE | 57132-3 |